J&J to Explore Options for Its Ortho Clinical Diagnostics Unit

Johnson & Johnson (JNJ) will review options for its Ortho Clinical Diagnostics business, which may include selling off the unit.

“At this time it is not certain that any transaction will be consummated,” the New Brunswick, New Jersey-based company said in a statement today.

To contact the reporter on this story: Bruce Rule in London at brule1@bloomberg.net

To contact the editor responsible for this story: Bruce Rule at brule1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.